ARCT
Arcturus Therapeutics Ltd
Halal Rating :
Last Price
$16.76
Last updated:
Market Cap
-
7D Change
-3.18%
1 Year Change
-50.91%
Company Overview
Industries
Exchange
Next Earnings Date
Arcturus Therapeutics Holdings Inc. is a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. The company's diverse pipeline of RNA therapeutic and vaccine candidates includes self-replicating mRNA vaccine programs for SARS-CoV-2 (COVID-19) and Influenza, and other programs to potentially treat ornithine transcarbamylase deficiency and cystic fibrosis.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $41.67m | $52.41m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $49.86m | $70.98m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $38.01m | $68.42m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Arcturus Therapeutics Ltd's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.